Dashboard
Manage Tickers

TELATELA Bio, Inc.

Nasdaq telabio.com


$ 5.51 $ -0.09 (-1.6 %)    

Friday, 31-May-2024 15:59:42 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ -0.84 (-0.19 %)
DIA $ 398.57 $ 6.05 (1.59 %)
SPY $ 530.36 $ 4.76 (0.91 %)
TLT $ 91.26 $ 0.61 (0.68 %)
GLD $ 225.37 $ -1.27 (-0.59 %)
$ 5.53
$ 5.68
$ 5.51 x 131
$ 0.00 x 0
$ 5.38 - $ 5.70
$ 4.23 - $ 11.26
137,756
na
135.92M
$ 1.08
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 03-22-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-23-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-11-2022 03-31-2022 10-Q
10 03-23-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-14-2021 03-31-2021 10-Q
14 03-25-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-Q
17 05-15-2020 03-31-2020 10-Q
18 03-30-2020 12-31-2019 10-K
19 12-18-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

piper-sandler-reiterates-overweight-on-tela-bio-lowers-price-target-to-10
Piper Sandler Reiterates Overweight on TEL...
05/10/2024 13:26:20

Piper Sandler analyst Matt O'Brien reiterates TELA Bio (NASDAQ:TELA) with a Overweight and lowers the price target from ...

tela-bio-increases-fy24-revenue-guidance-from-74m-76m-to-745m-765m-est-7494m
TELA Bio Increases FY24 Revenue Guidance F...
05/09/2024 21:33:44

tela-bio-q1-2024-adj-eps-054-misses-050-estimate-sales-16603m-beat-16319m-estimate
TELA Bio Q1 2024 Adj EPS $(0.54) Misses $(...
05/09/2024 21:15:13

TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.50) by...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
05/09/2024 20:31:07

tela-bio-announces-us-commercial-launch-of-robotic-compatible-ovitex-ihr-designed-for-use-in-laparoscopic-and-robotic-assisted-inguinal-hernia-repair
TELA Bio Announces U.S. Commercial Launch ...
04/15/2024 11:28:42

jmp-securities-reiterates-market-outperform-on-tela-bio-maintains-15-price-target
JMP Securities Reiterates Market Outperfor...
03/22/2024 17:12:06

JMP Securities analyst David Turkaly reiterates TELA Bio (NASDAQ:TELA) with a Market Outperform and maintains $15 price target.

piper-sandler-maintains-overweight-on-tela-bio-lowers-price-target-to-12
Piper Sandler Maintains Overweight on TELA...
03/22/2024 14:15:18

Piper Sandler analyst Matt O'Brien maintains TELA Bio (NASDAQ:TELA) with a Overweight and lowers the price target from $...

tela-bio-expects-full-year-2024-revenue-of-74m-76m-representing-27-30-yy-growth-est-75196m
TELA Bio Expects Full Year 2024 Revenue Of...
03/21/2024 21:00:29

recap-tela-bio-q4-earnings
Recap: TELA Bio Q4 Earnings
03/21/2024 20:20:12

tela-bio-q4-2023-gaap-eps-053-misses-044-estimate-sales-16998m-beat-16392m-estimate
TELA Bio Q4 2023 GAAP EPS $(0.53) Misses $...
03/21/2024 20:16:52

TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.44) by...

tela-bio-disclosed-us-commercial-launch-of-liquifix--the-only-fda-approved-liquid-adhesive-for-internal-use-in-hernia-surgery
TELA Bio Disclosed U.S. Commercial Launch ...
03/21/2024 11:12:32

earnings-scheduled-for-march-21-2024
Earnings Scheduled For March 21, 2024
03/21/2024 10:15:14

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per s...

preview-tela-bios-earnings
Preview: TELA Bio's Earnings
03/20/2024 16:01:01

Core News & Articles
Tela Bio Announced Sale Of Distribution Ri...
03/20/2024 11:13:48

lake-street-reiterates-buy-on-tela-bio-maintains-14-price-target
Lake Street Reiterates Buy on TELA Bio, Ma...
12/27/2023 14:31:21

Lake Street analyst Frank Takkinen reiterates TELA Bio (NASDAQ:TELA) with a Buy and maintains $14 price target.

jmp-securities-maintains-market-outperform-on-tela-bio-lowers-price-target-to-15
JMP Securities Maintains Market Outperform...
11/10/2023 19:52:45

JMP Securities analyst David Turkaly maintains TELA Bio (NASDAQ:TELA) with a Market Outperform and lowers the price target f...

tela-bio-sees-fy23-57m-60m-vs-6164m-est
TELA Bio Sees FY23 $57M-$60M Vs $61.64M Est.
11/09/2023 23:05:23

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
11/09/2023 21:31:10

recap-tela-bio-q3-earnings
Recap: TELA Bio Q3 Earnings
11/09/2023 21:30:47

tela-bio-q3-2023-eps-045-beats-049-estimate-sales-1505m-miss-1620m-estimate
TELA Bio Q3 2023 EPS $(0.45) Beats $(0.49)...
11/09/2023 21:25:54

TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.49) by 8...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION